Cargando…

Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study)

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of hospitalizations in children (≤5 years of age); limited data compare burden by age. METHODS: This single-center retrospective study included children (≤5 years of age) hospitalized for >24 hours with reverse-transcription polymer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartmann, Katrin, Liese, Johannes G, Kemmling, Daniel, Prifert, Christiane, Weißbrich, Benedikt, Thilakarathne, Pushpike, Diels, Joris, Weber, Karin, Streng, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417125/ https://www.ncbi.nlm.nih.gov/pubmed/35417015 http://dx.doi.org/10.1093/infdis/jiac137

Ejemplares similares

Novel Respiratory Syncytial Virus A Genotype, Germany, 2011–2012
por: Prifert, Christiane, et al.
Publicado: (2013)

Spread and clinical severity of respiratory syncytial virus A genotype ON1 in Germany, 2011–2017
por: Streng, Andrea, et al.
Publicado: (2019)

Continued high incidence of children with severe influenza A(H1N1)pdm09 admitted to paediatric intensive care units in Germany during the first three post-pandemic influenza seasons, 2010/11–2012/13
por: Streng, Andrea, et al.
Publicado: (2015)

Similar severity of influenza primary and re-infections in pre-school children requiring outpatient treatment due to febrile acute respiratory illness: prospective, multicentre surveillance study (2013–2015)
por: Streng, Andrea, et al.
Publicado: (2022)

Different epidemiological characteristics of respiratory virus infections in children and adults
por: Prifert, Christiane, et al.
Publicado: (2016)

Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders
por: Lehners, Nicola, et al.
Publicado: (2016)

Very Low Incidence of SARS-CoV-2, Influenza and RSV but High Incidence of Rhino-, Adeno- and Endemic Coronaviruses in Children With Acute Respiratory Infection in Primary Care Pediatric Practices During the Second and Third Wave of the SARS-CoV-2 Pandemic
por: Engels, Geraldine, et al.
Publicado: (2022)

Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML)
por: Tomeczkowski, Jörg, et al.
Publicado: (2015)

Novel Respiratory Syncytial Virus (RSV) Genotype ON1 Predominates in Germany during Winter Season 2012–13
por: Tabatabai, Julia, et al.
Publicado: (2014)

Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years
por: Del Riccio, Marco, et al.
Publicado: (2023)

Clinical characteristics of pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Northern Bavaria, Germany
por: Wieching, Anna, et al.
Publicado: (2012)

Transmission of Respiratory Syncytial Virus Infection Within Families
por: Heikkinen, Terho, et al.
Publicado: (2014)

Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness
por: ElSherif, May, et al.
Publicado: (2023)

Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study
por: Narejos Pérez, Sílvia, et al.
Publicado: (2023)

Epidemiology and Characteristics of Respiratory Syncytial Virus Pneumonia in Critically Ill Adults
por: Kim, Taeeun, et al.
Publicado: (2023)

Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children
por: Mazur, Natalie I., et al.
Publicado: (2017)

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
por: Pastula, Susan T., et al.
Publicado: (2017)

Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient
por: Besteman, Sjanna B, et al.
Publicado: (2022)

Estimation of the Number of Respiratory Syncytial Virus–Associated Hospitalizations in Adults in the European Union
por: Osei-Yeboah, Richard, et al.
Publicado: (2023)

High prevalence of antibodies against polyomavirus WU, polyomavirus KI, and human bocavirus in German blood donors
por: Neske, Florian, et al.
Publicado: (2010)

Factors Predicting Secondary Respiratory Morbidity Following Early-Life Respiratory Syncytial Virus Infections: Population-Based Cohort Study
por: Sarna, Mohinder, et al.
Publicado: (2023)

Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis
por: Onwuchekwa, Chukwuemeka, et al.
Publicado: (2023)

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
por: Sadoff, Jerald, et al.
Publicado: (2021)

Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract
por: Dee, Kieran, et al.
Publicado: (2022)

Retinoic Acid–Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection
por: Schwab, Lara S U, et al.
Publicado: (2022)

Transmission of Respiratory Syncytial Virus Among Children Under 5 Years in Households of Rural Communities, the Philippines
por: Otomaru, Hirono, et al.
Publicado: (2019)

Impact of the Coronavirus Disease 2019 Pandemic on the Clinical Features of Pediatric Respiratory Syncytial Virus Infection in Japan
por: Ozeki, Shoko, et al.
Publicado: (2022)

Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial
por: Fong, Youyi, et al.
Publicado: (2023)

The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya
por: Nyawanda, Bryan O, et al.
Publicado: (2020)

Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States
por: DeMartino, Jessica K, et al.
Publicado: (2023)

Respiratory Syncytial Virus Incidence and Severity in a Community-Based Prospective Cohort of Children Aged 0–14 Years
por: Smith, Matthew, et al.
Publicado: (2022)

Pneumococcal Conjugate Vaccines Are Protective Against Respiratory Syncytial Virus Hospitalizations in Infants: A Population-Based Observational Study
por: Le, Huong, et al.
Publicado: (2023)

Viral Genetic Determinants of Prolonged Respiratory Syncytial Virus Infection Among Infants in a Healthy Term Birth Cohort
por: Lawless, Dylan, et al.
Publicado: (2022)

Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
por: Jordan, Elke, et al.
Publicado: (2023)

Age-Dependent Risk of Respiratory Syncytial Virus Infection: A Systematic Review and Hazard Modeling From Serological Data
por: Nakajo, K, et al.
Publicado: (2023)

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings( )
por: Langley, Joanne M, et al.
Publicado: (2022)

Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6–59 Months Old During Four Seasons
por: Simpson, Melissa D., et al.
Publicado: (2016)

Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis
por: Onwuchekwa, Chukwuemeka, et al.
Publicado: (2023)

Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income Countries
por: Njue, Annete, et al.
Publicado: (2023)

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age
por: Díez-Domingo, Javier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98s75pt42hupnnf402rbevk63i